|
Thomas N. Konatich has served as Chief Financial Officer and Treasurer for SIGA since he joined SIGA in April of 1998. From October 2001 to July 2004 he served as SIGA's Acting Chief Executive Officer. Mr. Konatich again became Acting Chief Executive Officer on May 1, 2006. From November 1996 through March 1998, Mr. Konatich served as Chief Financial Officer and a Director of Innapharma, Inc., a privately held pharmaceutical development company. From 1993 through November 1996, Mr. Konatich served as Vice President and Chief Financial Officer of Seragen, Inc., a publicly traded biopharmaceutical development company. Mr. Konatich has an MBA from the Columbia Graduate School of Business.
| 